Developing Correlation Between In Silico Molecular Modeling and In Vitro α‐Amylase, Anti‐Cancer and SARS‐COV‐2 Studies of Bis‐Indole Derived Triazine‐Based Thiazolidinone Hybrid Derivatives
Authors:
- 24 June 2024
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 9 (24)
Abstract
In the era of COVID‐19 most of the marketed drugs have been found with some negative effects as well as with fewer numbers in the market. There is a serious need of an anti‐COVID agent which can maintain the normal body function with fewer or no side effects. For this purpose, hybrid derivatives based on bis‐indole derived triazine based thiazolidinone derivatives ( 1 – 12 ) were successfully synthesized and characterized using various spectroscopic techniques including 1 H NMR, 13 C NMR and HREI‐MS. All the synthesized bis‐indole derived triazine‐bearing thiazolidinone derivatives were tested for in vitro α‐amylase, cancer cell and SARS‐COV‐2 enzymes under the positive control of Acarbose, Tetrandrine and GC‐376 as standard drugs. All derivatives showed varied range of biological activities against target enzymes having IC 50 values ranging from 3.10±0.20 to 25.80±0.20 μM (α‐amylase), 0.20±0.30 to 19.10±0.20 μM (ant‐cancer) and 3.20±0.20 to 16.20±0.30 μM (SARS‐COV‐2), respectively. Specifically, derivatives 1, 3, 6, 8 and 9 were found to significantly active against target enzymes. Furthermore, the molecular docking approach was used to explore the binding interactions established by most active derivatives with the active sites of target enzymes and results corroborated that these active compounds developed several key interactions with the target enzymes and hence enhanced the enzymatic activities. Additionally, ADME prediction for the synthesized compounds were also explored which shows drug likeness of the synthesized compounds.Keywords
This publication has 38 references indexed in Scilit:
- Synthesis, in vitro biological analysis and molecular docking studies of new thiadiazole-based thiourea derivatives as dual inhibitors of a-amylase and a-glucosidaseArabian Journal of Chemistry, 2023
- Bis-indole based triazine derivatives: Synthesis, characterization, in vitro β-glucuronidase anti-cancer and anti-bacterial evaluation along with in silico molecular docking and ADME analysisArabian Journal of Chemistry, 2023
- Synthesis, in vitro thymidine phosphorylase inhibitory activity and molecular docking study of novel pyridine-derived bis-oxadiazole bearing bis-schiff base derivativesArabian Journal of Chemistry, 2023
- Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studiesBioorganic Chemistry, 2021
- Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agentsArchiv der Pharmazie, 2020
- New triazinoindole bearing thiazole/oxazole analogues: Synthesis, α-amylase inhibitory potential and molecular docking studyBioorganic Chemistry, 2019
- Protease inhibitors broadly effective against feline, ferret and mink coronavirusesAntiviral Research, 2018
- 1,2,4-Triazino-[5,6b]indole derivatives: effects of the trifluoromethyl group on in vitro antimalarial activityBioorganic & Medicinal Chemistry, 2005
- Thiourea and thiosemicarbazide derivatives: Structure, transformations, and pharmacological activity. Part II. Antihypoxic activity of 1,2,4-triazino[5,6-b]indole derivativesPharmaceutical Chemistry Journal, 1997
- New 5H-1,2,4-triazino[5,6-b]indole and aminoindole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation, anti-hypertensive agents and thromboxane synthetase inhibitorsEuropean Journal of Medicinal Chemistry, 1991